Cancer Informatics for Cancer Centers (CI4CC): Building a Community Focused on Sharing Ideas and Best Practices to Improve Cancer Care and Patient Outcomes.
Journal
JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
entrez:
21
2
2020
pubmed:
23
2
2020
medline:
9
3
2021
Statut:
ppublish
Résumé
Cancer Informatics for Cancer Centers (CI4CC) is a grassroots, nonprofit 501c3 organization intended to provide a focused national forum for engagement of senior cancer informatics leaders, primarily aimed at academic cancer centers anywhere in the world but with a special emphasis on the 70 National Cancer Institute-funded cancer centers. Although each of the participating cancer centers is structured differently, and leaders' titles vary, we know firsthand there are similarities in both the issues we face and the solutions we achieve. As a consortium, we have initiated a dedicated listserv, an open-initiatives program, and targeted biannual face-to-face meetings. These meetings are a place to review our priorities and initiatives, providing a forum for discussion of the strategic and pragmatic issues we, as informatics leaders, individually face at our respective institutions and cancer centers. Here we provide a brief history of the CI4CC organization and meeting highlights from the latest CI4CC meeting that took place in Napa, California from October 14-16, 2019. The focus of this meeting was "intersections between informatics, data science, and population science." We conclude with a discussion on "hot topics" on the horizon for cancer informatics.
Identifiants
pubmed: 32078367
doi: 10.1200/CCI.19.00166
pmc: PMC7186581
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108-116Subventions
Organisme : NCI NIH HHS
ID : R37 CA229810
Pays : United States
Références
Cancer Res. 2017 Nov 1;77(21):e3-e6
pubmed: 29092927
Cancer Res. 2017 Nov 1;77(21):e79-e82
pubmed: 29092946
Nature. 2015 Apr 9;520(7546):151-2
pubmed: 25855439
Gastroenterology. 2014 Apr;146(4):950-60
pubmed: 24417818
Cancer Causes Control. 2019 Jun;30(6):663-670
pubmed: 31004232
Cancer Prev Res (Phila). 2015 Sep;8(9):826-34
pubmed: 26314797
Science. 1994 Oct 7;266(5182):120-2
pubmed: 7939630
Oncotarget. 2016 Dec 27;7(52):85785-85797
pubmed: 27589689
JAMA. 2015 Jun 2;313(21):2117-8
pubmed: 26034952
Cell Rep. 2018 Apr 3;23(1):181-193.e7
pubmed: 29617659
N Engl J Med. 2019 Aug 15;381(7):668-676
pubmed: 31412182
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12595-12602
pubmed: 30530682
JCO Clin Cancer Inform. 2019 Jul;3:1-15
pubmed: 31335166
Future Oncol. 2016;12(8):997-1000
pubmed: 26863203
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
PLoS One. 2016 Feb 10;11(2):e0148697
pubmed: 26862893
Science. 1994 Apr 15;264(5157):436-40
pubmed: 8153634
J Am Med Inform Assoc. 2014 Jul-Aug;21(4):621-6
pubmed: 24780722
AMIA Jt Summits Transl Sci Proc. 2019 May 06;2019:173-181
pubmed: 31258969
Nat Rev Gastroenterol Hepatol. 2011 Mar;8(3):141-50
pubmed: 21383670
JAMA. 2018 Sep 18;320(11):1103-1104
pubmed: 30326503
J Natl Cancer Inst. 2018 Dec 1;110(12):1342-1351
pubmed: 29741696
Acad Med. 2018 Mar;93(3):451-455
pubmed: 29045273